Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Med.

Sec. Nephrology

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1654203

This article is part of the Research TopicModifiable Risk Factors for Chronic Kidney Disease ProgressionView all 15 articles

Concurrent Anti-Glomerular Basement Membrane Disease and Membranous Nephropathy: A Case Report

Provisionally accepted
Lin-Lin  LiLin-Lin Li*Pei-Yuan  NiuPei-Yuan NiuNa  LiNa LiXiao-Ling  ZhangXiao-Ling ZhangHuixai  CaoHuixai Cao
  • Henan Provincial People's Hospital, Zhengzhou, China

The final, formatted version of the article will be published soon.

Anti-glomerular basement membrane (GBM) disease is a rapidly progressive glomerulonephritis which, in rare instances, occurs concurrently with membranous nephropathy (MN). We report a case of this patient presented with proteinuria and hematuria, the predominant pathology was crescentic and necrotizing glomerulonephritis with linear staining for immunoglobulin G (IgG) along the glomerular basement membrane (GBM) associated with epi-membranous electron dense immune deposits. The patient tested had significant titers of anti-GBM antibodies (196.27 RU/ml;reference range:0-20 RU/ml), and renal biopsy demonstrated diffuse strongly positive granular staining for phospholipase a2 receptor (PLA2R) along the GBM. The patient received therapy including prednisone, plasmapheresis and CD20 antibodies, which resulted in the clearance of anti-GBM antibodies and eventual recovery of renal function, as evidenced by the return of serum creatinine to normal levels. Earlier diagnosis and timely effective treatments could improve patients' prognosis.

Keywords: anti-glomerular basement membrane (GBM) disease, Membranous nephropathy (MN), diagnosis, Phospholipase A2 receptor (PLA2R), Treatment, prognosis

Received: 26 Jun 2025; Accepted: 18 Sep 2025.

Copyright: © 2025 Li, Niu, Li, Zhang and Cao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Lin-Lin Li, 18811539580@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.